Research Article
Therapeutic Effect of P-Cymene on Lipid Profile, Liver Enzyme, and Akt/Mtor Pathway in Streptozotocin-Induced Diabetes Mellitus in Wistar Rats
Figure 5
The expression of Akt, pAkt (phospho-Akt), and mTOR protein. Statistically different from the control rats (), statistically different from the control rats (), ##statistically different from the sham rats (), ###statistically different from the sham rats (), +statistically different from the Met rats (), ++statistically different from the Met rats (), +++statistically different from the Met rats (). C: control rats, D: the sham or diabetic rats, MET: diabetic rats + metformin (55 mg/kg), C25: control rats + p-cymene (25 mg/kg), C50: control rats + p-cymene (50 mg/kg), C100: control rats + p-cymene (100 mg/kg), D25: diabetic rats + p-cymene (25 mg/kg), D50: diabetic rats + p-cymene (50 mg/kg), and D100: diabetic rats + p-cymene (100 mg/kg).